Adaptive Biotechnologies Corp - ESG Rating & Company Profile powered by AI
This ESG rating for Adaptive Biotechnologies Corp indicates its transparency towards the United Nations SDGs. If you work at Adaptive Biotechnologies Corp and you would like to use your Sustainability rating, please contact us. The webpage contains a free E,S&G assessment for Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.8; made up of an environmental score of 2.7, social score of 4.6 and governance score of 4.0.
3.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1089 | Zymeworks Inc | 3.9 | Medium |
| 1089 | bluebird bio Inc | 3.9 | Medium |
| 1112 | Adaptive Biotechnologies Corp | 3.8 | Medium |
| 1112 | AcelRx Pharmaceuticals Inc | 3.8 | Medium |
| 1112 | Arcus Biosciences Inc | 3.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Adaptive Biotechnologies Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp report the average age of the workforce?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp offer flexible work?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp conduct supply chain audits?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Adaptive Biotechnologies Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose water use targets?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Adaptive Biotechnologies Corp have a product recall in the last two years?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Adaptive Biotechnologies Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose parental leave metrics?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Adaptive Biotechnologies Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose its waste policy?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp report according to TCFD requirements?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose energy use targets?
Sign up for free to unlockDoes Adaptive Biotechnologies Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Adaptive Biotechnologies Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Adaptive Biotechnologies Corp
These potential risks are based on the size, segment and geographies of the company.
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.